P-33 Long-acting injectable regimen with cabotegravir + rilpivirine in people living with HIV: real-life experience from Modena HIV clinic

Alessandra Soffritti(Azienda Ospedaliero-Universitaria di Modena), Cristina Mussini(University of Modena and Reggio Emilia), Marianna Menozzi(Azienda Ospedaliero-Universitaria di Modena), A Cervo(Azienda Ospedaliero-Universitaria di Modena)
Poster
June 1, 2024
10.1136/sextrans-icar-2024.154
Cited by 1

Related Papers

Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity
|AIDS|2015|174